C. diff increases mortality risk in cirrhosis patients

Cirrhosis patients who also are infected with Clostridium difficile had higher mortality rates and lengths of stay, according to research presented at the Interscience Conference on Antimicrobial Agents and Chemotherapy.

Advertisement

Researchers compared and analyzed C. diff incidence rates from 2009 and found cirrhotic patients with C. diff had an average in-hospital mortality rate of 15.9 percent, compared with 8.9 percent of cirrhotic patients without C. diff. Additionally, the average length of stay for cirrhotic patients with C. diff was 9.11 days longer than for cirrhotic patients without C. diff.

Researchers suggest further research is needed to reduce the C. diff burden for cirrhotic patients.

More articles on HAIs:

LA BioMed receives NIH grant to study HAI vaccines
Pre-surgical skin antisepsis: A call to reduce variability to improve quality
Children’s HAI rates plummet

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Clinical Leadership & Infection Control

Advertisement

Comments are closed.